Drug Information

Drug General Information
Drug ID
D0D5CY
Former ID
DIB008170
Drug Name
Pradefovir
Synonyms
Remofovir; Pradefovir mesylate; Remofovir mesylate; Hepavir-B; ICN 2001-3; MB-06866; MB-6866; Pradefovir (oral, hepatitis B), Ligand/Chiva
Drug Type
Small molecular drug
Indication Hepatitis virus infection [ICD9: 573.3; ICD10:K75.9] Phase 2 [521736]
Company
Metabasis Therapeutics Inc
Structure
Download
2D MOL

3D MOL
Formula
C17H19ClN5O4P
Canonical SMILES
[P@@]1(=O)(O[C@H](c2cc(Cl)ccc2)CCO1)COCCn1c2c(nc1)c(ncn<br />2)N
PubChem Compound ID
58823201
Target and Pathway
Target(s) DNA polymerase/reverse transcriptase Target Info Modulator
References
Ref 521736ClinicalTrials.gov (NCT00230503) Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.